Department of Cardiovascular Surgery, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart, Lung and Vessel Disease, Beijing, People's Republic of China.
Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.
Braz J Cardiovasc Surg. 2022 Sep 2;37(Spec 1):69-78. doi: 10.21470/1678-9741-2022-0189.
This single-center study of propensity-matched data was performed to assess the effect of the no-touch saphenous vein (NTSV) harvesting technique on early- and long-term outcomes of patients after off-pump coronary artery bypass grafting (OPCABG) in China.
A retrospective analysis of 767 patients who underwent OPCABG in the Beijing Anzhen Hospital (June 2017 to October 2021) was performed, and their data entered the conventional saphenous vein (CSV) harvesting technique group or the NTSV group. In-hospital and follow-up outcomes were evaluated by adjusting baseline characteristics using propensity score matching (1:1). Clinical outcomes and postoperative angiographic results were compared.
The saphenous vein graft patency rates at postoperative three months and one year for the NTSV group vs. CSV group were 99.6% vs. 96.2% (P<0.001) and 97.3% vs. 93.1% (P<0.001), respectively. The two matched groups received a significantly different cumulative incidence function of saphenous vein graft occlusion for the longer follow-up period in Kaplan-Meier curves (χ=4.330, log-rank P=0.037). No difference in early- and long-term mortality or major adverse cardiac and cerebrovascular events (MACCE) were observed between the groups. The rate of MACCE was not statistically significant different between the groups, but there was a tendency favoring the no-touch technique (9.8% CSV vs. 4.8% NTSV; P=0.067). More patients in the NTSV group developed postoperative leg wound exudation (5.4% vs. 1.2%; P=0.032) and skin numbness (22.2% vs. 8.9%; P=0.001) than in the CSV group.
The NTSV is an excellent conduit to be used in OPCABG. There remains a need to reduce leg wound complications.
本单中心倾向性匹配研究旨在评估在中国行非体外循环冠状动脉旁路移植术(OPCABG)中,应用非接触式大隐静脉(NTSV)采集技术对患者早期和长期结果的影响。
对 2017 年 6 月至 2021 年 10 月在北京安贞医院行 OPCABG 的 767 例患者进行回顾性分析,将其数据纳入常规大隐静脉(CSV)采集技术组或 NTSV 组。通过倾向评分匹配(1:1)调整基线特征,评估住院和随访结果。比较临床结果和术后血管造影结果。
NTSV 组与 CSV 组术后 3 个月和 1 年大隐静脉桥通畅率分别为 99.6% vs. 96.2%(P<0.001)和 97.3% vs. 93.1%(P<0.001)。两组患者在 Kaplan-Meier 曲线中接受了更长随访时间的大隐静脉桥闭塞累积发生率的显著不同(χ=4.330,对数秩 P=0.037)。两组患者的早期和长期死亡率或主要心脏和脑血管不良事件(MACCE)无差异。两组 MACCE 发生率无统计学差异,但无接触技术有优势趋势(9.8% CSV 比 4.8% NTSV;P=0.067)。NTSV 组术后腿部伤口渗出(5.4%比 1.2%;P=0.032)和皮肤麻木(22.2%比 8.9%;P=0.001)的发生率明显高于 CSV 组。
NTSV 是 OPCABG 的一种优秀的移植物。仍需要减少腿部伤口并发症。